AdjustmentNCT07167719
Resilience in Reentry: Cognitive-Behavioral Resilience Training for Parolees With Adjustment Challenges
A study testing Cognitive Behavioral Therapy in people with Adjustment, run by University of California, Irvine at 1 site in United States.
Trial summary
This pilot study assesses the feasibility and acceptability of delivering a brief Cognitive-Behavioral Resiliency treatment to a population of recently released parolees. This study will also give a preliminary indication if the treatment is associated with reliable improvements in adjustment symptoms and well-being… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Adjustment
- What is being tested?
- Cognitive Behavioral Therapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteUnited States
- Study dates
- 27 Jan 2026to Jun 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 18 years or older
- Speaks English
- Been on parole for two years or less.
- Score of 8.5 or higher (range 4 to 16) on the Adjustment Disorder New Module 4 (ADNM-4) screening tool (Ben-Ezra, et al., 2018).
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
The Francisco Homes
Los Angeles, California, 90037
Teresa Groth, Sister (Catholic), +1 323-293-1111, info@thefranciscohomes.org
About this study
This pilot study assesses the feasibility and acceptability of delivering a brief Cognitive-Behavioral Resiliency treatment to a population of recently released parolees. This study will also give a preliminary indication if the treatment is associated with reliable improvements in adjustment symptoms and well-being for parolees.
Read the detailed description
In the proposed pilot study, residents of a reentry facility in Los Angeles, CA will be able to enroll in a course of brief (5-session) Cognitive-Behavioral Therapy (CBT) focused on building resiliency in response to the effects of institutionalization. Those who choose to receive the intervention will be included in the intervention group (target N = 30). Those who choose not to receive the intervention will be given the opportunity to complete assessments at the same intervals as the intervention group (assessment only group; target N = 30). Participants will report their degree of satisfaction with the program and how much they think they benefitted from the program at postintervention. Participants will complete self-report measures of adjustment disorder symptoms, flourishing, meaning and purpose in life, and PTSD symptoms at pretreatment (baseline), posttreatment (5 weeks after baseline), and 2-month follow-up (13 weeks after baseline).
- Conditions
- Adjustment
- Being tested
- Cognitive Behavioral Therapy
- Keywords
- Incarceration, Reentry
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cognitive Behavioral TherapyBehavioural
Also called CBT
Brief Cognitive-Behavioral Therapy (CBT) focused on building resiliency in response to the effects of institutionalization
| Study group | Role | What they receive |
|---|---|---|
| Treatment | Experimental | Participants will receive a 5-session CBT intervention Receives: Behavioral: Cognitive Behavioral Therapy |
| Assessment Only | No intervention | Participants will receive study assessments |
What is being measured
The primary outcome is the main question the study is designed to answer.
Adjustment Disorder New Module 20
The ADNM-20 is a self-report measure consisting of two parts: a stressor list and an item list. It is a 20-item measure that ranges from 20 to 80. Participants will fill out stressors from their prison term and will then complete the items which are composed of a 4-point Likert scales from "Never" to "Often."
Measured: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)
Flourishing Scale
The Flourishing Scale is an 8-item self-report measure (with a range of 8 to 56) of the respondent's self-perceived success in important areas such as relationships, self-esteem, purpose, and optimism. The scale provides a single psychological well-being score.
Measured: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)
PROMIS Meaning and Purpose Short Form 8a
The PROMIS Meaning and Purpose is an 8-item self-report measure with a range of 8 to 40 that assess one's sense of life having purpose and that there are good reasons for living. Higher scores indicate hopefulness, optimism, goal-directedness, and feelings that one's life is worthy.
Measured: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)
Secondary outcomes (1)
PTSD Checklist 5
This is an 8-item abbreviated version of the PTSD Checklist 5, a self-report measure which ranges from 0 to 32 that assesses the DSM-5 symptoms of PTSD.
Measured: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Sep 2025
- Study start27 Jan 2026
- Primary completionApr 2027 (estimated)
- Study completionJun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AdjustmentStudies of the same condition, open and under way.
- More trials run by University of California, IrvineThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- The study employees two arms: the treatment arm and an assessment only arm. The pilot study is non-randomized.
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of California, Irvine
- Sponsor type
- University, hospital or other
- Collaborators
- Massachusetts Institute of Technology
- Responsible party
- Principal investigator, Emily Greene Owens, University of California, Irvine
- Investigators
- Emily Owens, Study director, University of California, Irvine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07167719
- Sponsor's protocol ID
- 7520
- Status last verified
- Oct 2026
- First submitted
- 4 Sep 2025
- Last updated
- 8 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is a small sample size and the study participant's are a systemically vulnerable population.
Study at a glance
From the registry record, last updated by the sponsor on 8 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Resilience in Reentry: Cognitive-Behavioral Resilience Training for Parolees With Adjustment Challenges
- ClinicalTrials.gov ID
- NCT07167719
- Acronym / sponsor ID
- 7520
- Conditions
- Adjustment
- Keywords
- Incarceration, Reentry
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- University of California, IrvineUniversity, hospital or other
- Collaborators
- Massachusetts Institute of Technology
- Study start
- 27 Jan 2026 (actual)
- Primary completion
- Apr 2027 (estimated)
- Study completion
- Jun 2027 (estimated)
- First posted
- 11 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This pilot study assesses the feasibility and acceptability of delivering a brief Cognitive-Behavioral Resiliency treatment to a population of recently released parolees. This study will also give a preliminary indication if the treatment is associated with reliable improvements in adjustment symptoms and well-being for parolees.
Detailed description
In the proposed pilot study, residents of a reentry facility in Los Angeles, CA will be able to enroll in a course of brief (5-session) Cognitive-Behavioral Therapy (CBT) focused on building resiliency in response to the effects of institutionalization. Those who choose to receive the intervention will be included in the intervention group (target N = 30). Those who choose not to receive the intervention will be given the opportunity to complete assessments at the same intervals as the intervention group (assessment only group; target N = 30). Participants will report their degree of satisfaction with the program and how much they think they benefitted from the program at postintervention. Participants will complete self-report measures of adjustment disorder symptoms, flourishing, meaning and purpose in life, and PTSD symptoms at pretreatment (baseline), posttreatment (5 weeks after baseline), and 2-month follow-up (13 weeks after baseline).
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- The study employees two arms: the treatment arm and an assessment only arm. The pilot study is non-randomized.
| Arm | Type | Receives |
|---|---|---|
| Treatment | Experimental | Behavioral: Cognitive Behavioral TherapyParticipants will receive a 5-session CBT intervention |
| Assessment Only | No intervention | –Participants will receive study assessments |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- 18 years or older
- Speaks English
- Been on parole for two years or less.
- Score of 8.5 or higher (range 4 to 16) on the Adjustment Disorder New Module 4 (ADNM-4) screening tool (Ben-Ezra, et al., 2018).
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cognitive Behavioral TherapyAlso: CBTBrief Cognitive-Behavioral Therapy (CBT) focused on building resiliency in response to the effects of institutionalization | Behavioural | Treatment |
Primary outcome
Adjustment Disorder New Module 20
Time frame: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)
The ADNM-20 is a self-report measure consisting of two parts: a stressor list and an item list. It is a 20-item measure that ranges from 20 to 80. Participants will fill out stressors from their prison term and will then complete the items which are composed of a 4-point Likert scales from "Never" to "Often."
Flourishing Scale
Time frame: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)
The Flourishing Scale is an 8-item self-report measure (with a range of 8 to 56) of the respondent's self-perceived success in important areas such as relationships, self-esteem, purpose, and optimism. The scale provides a single psychological well-being score.
PROMIS Meaning and Purpose Short Form 8a
Time frame: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)
The PROMIS Meaning and Purpose is an 8-item self-report measure with a range of 8 to 40 that assess one's sense of life having purpose and that there are good reasons for living. Higher scores indicate hopefulness, optimism, goal-directedness, and feelings that one's life is worthy.
1 secondary outcome
PTSD Checklist 5
Time frame: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Oct 2026.
- Individual participant dataSharing planned: No. There is a small sample size and the study participant's are a systemically vulnerable population.
Related trials for Adjustment
Not yet recruiting
A Randomized Controlled SaCo-VLM Trial
General Anaesthesia Using Supraglotic Airway
Recruiting
Facial Expression Awareness Training to Understand and Recognize Emotions
Survivors of Pediatric Brain Tumors, Pediatric Cancer
Active, not recruiting
FreeDom: Innovative Strategy for the Management of COPD Exacerbations
Oxygen Deficiency, COPD Exacerbation
Active, not recruitingPhase 2
De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
Oropharyngeal Cancer
Recruiting
Effects of a Mindful Self-Compassion Intervention on Psychological Adjustment in Breast Cancer Survivors
Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Emily Owens study director
University of California, Irvine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cognitive Behavioral Therapy in people with Adjustment, run by University of California, Irvine at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Joanne B DeCaro (360-903-5503, jdecaro@uci.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Adjustment Disorder New Module 20 (time frame: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.